Pinealon Mechanism of Action
How Pinealon works: receptor targets, signalling pathways, and molecular profile.
A Khavinson-Group Peptide Bioregulator
Pinealon (EDR: Glu-Asp-Arg) is a synthetic tripeptide from the same research tradition as Epithalon — the 'peptide bioregulator' family developed by Vladimir Khavinson's group. The proposed mechanism is that short peptides like EDR bind complementarily to DNA promoter regions, modulating gene transcription directly — a hypothesis distinct from the receptor-agonist mechanisms most peptides in this catalog use, and one that remains contested and unreplicated outside the originating research group.
Neuroprotection Research Focus
Pinealon-specific research centers on neuroprotective and cognitive-aging effects in animal models, positioned within the Khavinson group's broader work on organ-specific 'bioregulator' peptides (Pinealon for brain/pineal tissue, similar to how their other tripeptides target other organ systems).